Laurent Riou PhD in Cellular Biology
Course and current status
Qualifications :
PhD in Cellular Biology, Grenoble University, 1999
HDR, Habilitation à Diriger des Recherches (Habilitation to Supervise Research), Grenoble University, 2006
Present Post :
Assistant Research Professor (CR1), INSERM, U1039, Radiopharmaceutiques Biocliniques, Grenoble, France
Past Positions:
2007-present : Assistant Research Professor (CR1), INSERM U1039, Radiopharmaceutiques Biocliniques, Grenoble, France
2003-2007 : Assistant Research Professor (CR2), INSERM E0008, Radiopharmaceutiques Biocliniques, Grenoble, France
1999-2003 : Post-docotoral fellow, Experimental NUclear Cardiology Laboratory, University of Viginia, Charlottesville, VA, USA
1996-99 : PhD student, Laboratoire d'Etudes de Radiopharmaceutiques, ESA CNRS 5077 / LRC CEA 10, Grenoble, France
Scientific summary
Our field of research relates to nuclear imaging and cardiovascular diseases. More specifically, our main objective is to develop new nuclear imaging agents for the early non invasive diagnosis and prognosis of cardiovascular conditions. Our initial PhD and post-doc work was focused on experimental studies on new myocardial perfusion and inflammation imaging agents for the non invasive diagnosis and prognosis of coronary artery disease. More recently, we worked on the experimental evaluation of potentially interesting novel agents for the molecular imaging of vulnerable atherosclerotic plaques for the identification of individual at high cardiovascular risk prior to the occurrence of a coronary event. Among those, the tracer 99mTc-B2702p1 will be clinically evaluated in the near future (ANR grant PLAQUIMAG). Another important area of interest relate to the non invasive assessment of coronary microvasculature using an original analysis of clinical and small animal nuclear perfusion images. We are also interested in the development and experimental validation of novel radiolabeling methodologies as well as new small animal imaging equipment through academic collaborations.
